(12) United States Patent (10) Patent No.: US 9,714.226 B2 Sandanayaka Et Al
USOO9714226B2 (12) United States Patent (10) Patent No.: US 9,714.226 B2 Sandanayaka et al. (45) Date of Patent: *Jul. 25, 2017 (54) HYDRAZIDE CONTAINING NUCLEAR (58) Field of Classification Search TRANSPORT MODULATORS AND USES CPC. C07D 249/08: C07D 403/12: C07D 401/12: THEREOF C07D 241/20; C07D 409/12: A61 K 31/497; A61K 31/4439; A61K 31/454; (71) Applicant: Karyopharm Therapeutics Inc., A61K 31/4196; A61K 3 1/506; A61 K Newton, MA (US) 31/498; A61K 31/55 USPC ....... 514/210.2, 255.05, 340, 326,383, 256, (72) Inventors: Vincent P. Sandanayaka, Northboro, 514/249, 217.09: 544/405, 328, 356; MA (US); Sharon Shacham, Newton, 546/272.4, 210: 548/267.6: 540/603 MA (US); Dilara McCauley, Arlington, See application file for complete search history. MA (US); Sharon Shechter, Andover, MA (US) (56) References Cited (73) Assignee: Karyopharm Therapeutics Inc., Newton, MA (US) U.S. PATENT DOCUMENTS 5,153,201 A 10, 1992 Aono et al. (*) Notice: Subject to any disclaimer, the term of this 5,817,677 A 10, 1998 Linz et al. patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. (Continued) This patent is Subject to a terminal dis FOREIGN PATENT DOCUMENTS claimer. CN 1O1309.912. A 11/2008 CN 101466687. A 6, 2009 (21) Appl. No.: 14/940,310 (Continued) (22) Filed: Nov. 13, 2015 OTHER PUBLICATIONS (65) Prior Publication Data * Final Office Action dated Feb. 27, 2015 for U.S. Appl. No. US 2016/0304472 A1 Oct. 20, 2016 13/350,864, "Olefin Containing Nuclear Transport Modulators and Uses Thereof.
[Show full text]